Formation of 1-beta-D-arabinofuranosylcytosine diphosphate choline in neoplastic and normal cells
- PMID: 274175
Formation of 1-beta-D-arabinofuranosylcytosine diphosphate choline in neoplastic and normal cells
Abstract
1-beta-D-Arabinofuranosylcytosine diphosphate choline was formed from 1-beta-D-arabinofuranosylcytosine (ara-C) during incubation in vitro of peripheral myeloblasts from patients with acute myelogenous leukemia and cultured cells (nonleukemic human lymphocytes, mouse lymphoma L5178Y, and HeLa); as well, 1-beta-D-arabinofuranosylcytosine diphosphate choline was formed in vivo in mouse leukemia L1210 cells and mouse liver. 3-Deazauridine enhanced the anabolism of ara-C in nonleukemic lymphocytes in vitro and leukemia L1210 cells in vivo but did not influence ara-C anabolism in the other cell types. In acute myelogenous leukemia myeloblasts incubated in vitro with ara-C, concentrations of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate were maximal after 8 hr of incubation and formation of the latter preceded that of 1-beta-D-arabinofuranosylcytosine diphosphate choline.
Similar articles
-
Formation of 1-beta-D-arabinofuranosylcytosine diphosphate choline in cultured human leukemic RPMI 6410 cells.Cancer Res. 1978 Jun;38(6):1723-9. Cancer Res. 1978. PMID: 274174
-
1-beta-D-arabinofuranosylcytosine-diphosphate-choline is formed by the reversal of cholinephosphotransferase and not via cytidylyltransferase.Cancer Res. 1992 Jul 15;52(14):3886-91. Cancer Res. 1992. PMID: 1377599
-
Cystathionine-beta-synthase cDNA transfection alters the sensitivity and metabolism of 1-beta-D-arabinofuranosylcytosine in CCRF-CEM leukemia cells in vitro and in vivo: a model of leukemia in Down syndrome.Cancer Res. 2000 Nov 15;60(22):6421-6. Cancer Res. 2000. PMID: 11103808
-
Substrate cycles and drug resistance to 1-beta-D-arabinofuranosylcytosine (araC).Leuk Lymphoma. 2005 Mar;46(3):335-46. doi: 10.1080/10428190400015683. Leuk Lymphoma. 2005. PMID: 15621823 Review.
-
Intracellular nucleotide pools and their significance in antimetabolite therapy.Antibiot Chemother (1971). 1980;28:68-77. doi: 10.1159/000386062. Antibiot Chemother (1971). 1980. PMID: 6998365 Review.
Cited by
-
Gemcitabine diphosphate choline is a major metabolite linked to the Kennedy pathway in pancreatic cancer models in vivo.Br J Cancer. 2014 Jul 15;111(2):318-25. doi: 10.1038/bjc.2014.288. Epub 2014 May 29. Br J Cancer. 2014. PMID: 24874484 Free PMC article.
-
The pharmacologic basis for the efficacy of high-dose Ara-C and sequential asparaginase in adult acute myelogenous leukemia.Yale J Biol Med. 1988 Jan-Feb;61(1):11-22. Yale J Biol Med. 1988. PMID: 3163212 Free PMC article. Clinical Trial.
-
Effect of uracil arabinoside on metabolism and cytotoxicity of cytosine arabinoside in L5178Y murine leukemia.J Clin Invest. 1985 Jan;75(1):141-6. doi: 10.1172/JCI111666. J Clin Invest. 1985. PMID: 4038404 Free PMC article.
-
Optimization of cytarabine (ARA-C) therapy for acute myeloid leukemia.Exp Hematol Oncol. 2013 Aug 6;2:20. doi: 10.1186/2162-3619-2-20. eCollection 2013. Exp Hematol Oncol. 2013. PMID: 23919448 Free PMC article.
-
Response and Toxicity to Cytarabine Therapy in Leukemia and Lymphoma: From Dose Puzzle to Pharmacogenomic Biomarkers.Cancers (Basel). 2021 Feb 25;13(5):966. doi: 10.3390/cancers13050966. Cancers (Basel). 2021. PMID: 33669053 Free PMC article. Review.